Multicomponent Prehabilitation in Older Adults With Breast Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorFundacion Miguel Servet

About this trial

Older adults with breast cancer frequently present with frailty, decreased functional reserve, and increased risk of postoperative complications. Prehabilitation programs have emerged as a promising strategy to improve physical function and clinical outcomes; however, evidence in geriatric oncology remains limited, particularly regarding the role of biological markers in predicting response to such interventions.

This study aims to evaluate the effectiveness of a multicomponent prehabilitation program in older adults with breast cancer, focusing on functional status, clinical outcomes, and quality of life. In addition, the study seeks to characterize biological markers associated with frailty and treatment response, with the goal of identifying potential predictors of benefit from prehabilitation.

Participants will undergo a structured prehabilitation intervention including physical exercise, nutritional optimization, and comprehensive geriatric assessment. Clinical, functional, and biomarker data will be collected longitudinally.

The results of this study may contribute to improving personalized care strategies in geriatric oncology and to identifying patients who are most likely to benefit from prehabilitation programs.

Eligibility criteria

Qualifiers

Age ≥65 years

Diagnosis of cancer requiring elective surgery with curative intent

Candidate for prehabilitation program before surgery

Ability to walk (with or without assistive devices)

Disqualifiers

Urgent or emergency surgery

Severe cognitive impairment precluding participation in the intervention

Severe functional dependency (e.g., bedridden patients)

Medical contraindication to physical exercise

Trial design

Treatments tested in this trial

  • Home-based Multicomponent Prehabilitation (Vivifrail)
  • Supervised Multicomponent Prehabilitation
  • Comprehensive Geriatric Assessment and Optimization

Treatment groups

90 Participants
are divided into 3 treatment groups

Sponsors and collaborators